Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, pharmacy benefits manager Catamaran (CTRX.DL) has earned a respected four-star ranking.
With that in mind, let's take a closer look at Catamaran and see what CAPS investors are saying about the stock right now.
Catamaran facts
|
Headquarters (founded) |
Lisle, Ill. (1993) |
|
Market Cap |
$10.8 billion |
|
Industry |
Healthcare services |
|
Trailing-12-Month Revenue |
$8.0 billion |
|
Management |
Chairman/CEO Mark Thierer (since 2012) |
|
Return on Equity (average, past 3 years) |
10.3% |
|
Cash/Debt |
$393.0 million / $1.3 billion |
|
Competitors |
Caremark Pharmacy Services |
Sources: S&P Capital IQ and Motley Fool CAPS.
On CAPS, 95% of the 362 members who have rated Catamaran believe the stock will outperform the S&P 500 going forward.
Just yesterday, one of those Fools, All-Star echofarmer, took a cautiously bullish stance on Catamaran: "Good cash flow and earnings growth history. The main financial con as I see it is the razor thin [profit margins]. Yikes! Not much room for error here, but good cash position to survive any missteps."
Want to see how well (or not so well) the stocks in this series are performing? Follow the TrackPoisedTo CAPS account.
